Company / Total Assets
ATOSSA THERAPEUTICS, INC. Total Assets History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$6.2M
FY2016
5-year range
$6.2M / $12.0M
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $12M to $6M over the past 2 years.
Based on SEC 10-K filings.
$6M in FY2016 with a 3-year CAGR of -19.6%.
Declined from $12M to $6M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -19.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -19.6%, indicating a declining trend.
- In FY2016, total assets increased 0.0% year-over-year.
- Peak total assets was recorded in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $6.2M | +0.0% |
| FY2015 | $6.2M | -46.9% |
| FY2014 | $11.8M | -2.0% |
| FY2013 | $12.0M | +75.9% |
| FY2012 | $6.8M | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026